• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Fibrinolytic profile depends on disease severity in pediatric patients with cirrhosis: illustration by 2 different plasma-based fibrinolysis assays.

作者信息

van Dievoet Marie-Astrid, Zouaoui Boudjeltia Karim, Rousseaux Madeleine, Douxfils Jonathan, Lisman Ton, Stephenne Xavier

机构信息

Laboratory of Pediatric Hepatology and Cell Therapy, Institut de Recherche Expérimentale et Clinique (IREC), Université Catholique de Louvain, Brussels, Belgium.

Laboratory Department, Cliniques Universitaires Saint-Luc, Brussels, Belgium.

出版信息

Res Pract Thromb Haemost. 2024 Aug 20;8(6):102551. doi: 10.1016/j.rpth.2024.102551. eCollection 2024 Aug.

DOI:10.1016/j.rpth.2024.102551
PMID:39290990
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11406019/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/384e/11406019/e0c757ef7861/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/384e/11406019/6915071c8f62/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/384e/11406019/e0c757ef7861/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/384e/11406019/6915071c8f62/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/384e/11406019/e0c757ef7861/gr2.jpg

相似文献

1
Fibrinolytic profile depends on disease severity in pediatric patients with cirrhosis: illustration by 2 different plasma-based fibrinolysis assays.纤溶谱取决于肝硬化患儿的疾病严重程度：通过两种不同的基于血浆的纤溶测定法说明
Res Pract Thromb Haemost. 2024 Aug 20;8(6):102551. doi: 10.1016/j.rpth.2024.102551. eCollection 2024 Aug.
2
Evidence for an enhanced fibrinolytic capacity in cirrhosis as measured with two different global fibrinolysis tests.两种不同的全血栓溶解试验检测肝硬化患者纤维蛋白溶解能力增强的证据。
J Thromb Haemost. 2012 Oct;10(10):2116-22. doi: 10.1111/j.1538-7836.2012.04901.x.
3
Intraperitoneal Activation of Coagulation and Fibrinolysis in Patients with Cirrhosis and Ascites.肝硬化伴腹水患者腹腔内凝血和纤溶激活。
Thromb Haemost. 2022 Mar;122(3):353-362. doi: 10.1055/a-1515-9529. Epub 2021 Jul 4.
4
Thrombin-activatable fibrinolysis inhibitor deficiency in cirrhosis is not associated with increased plasma fibrinolysis.肝硬化患者中凝血酶激活的纤维蛋白溶解抑制剂缺乏与血浆纤维蛋白溶解增加无关。
Gastroenterology. 2001 Jul;121(1):131-9. doi: 10.1053/gast.2001.25481.
5
The Fibrinolytic Status in Liver Diseases.肝脏疾病中的纤维蛋白溶解状态。
Semin Thromb Hemost. 2015 Jul;41(5):474-80. doi: 10.1055/s-0035-1550437. Epub 2015 Jun 6.
6
The pathogenesis of accelerated fibrinolysis in liver cirrhosis: a critical role for tissue plasminogen activator inhibitor.肝硬化中纤维蛋白溶解加速的发病机制：组织纤溶酶原激活物抑制剂的关键作用。
Blood. 1987 May;69(5):1315-9.
7
Altered clot formation and lysis are associated with increased fibrinolytic activity in ascites in patients with advanced cirrhosis.晚期肝硬化患者腹水存在纤维蛋白溶解活性增加，与之相关的是血栓形成和溶解的改变。
Intern Emerg Med. 2021 Mar;16(2):339-347. doi: 10.1007/s11739-020-02375-3. Epub 2020 May 22.
8
Mixed Fibrinolytic Phenotypes in Decompensated Cirrhosis and Acute-on-Chronic Liver Failure with Hypofibrinolysis in Those With Complications and Poor Survival.失代偿期肝硬化和慢加急性肝衰竭中存在混合纤溶表型，且伴有并发症和生存不良者存在低纤溶。
Hepatology. 2020 Apr;71(4):1381-1390. doi: 10.1002/hep.30915. Epub 2019 Oct 24.
9
Haemostatic Profiles are Similar across All Aetiologies of Cirrhosis.各类病因所致肝硬化患者的止血谱相似。
Thromb Haemost. 2019 Feb;119(2):246-253. doi: 10.1055/s-0038-1676954. Epub 2019 Jan 4.
10
Does decreased fibrinolysis have a role to play in the development of non-neoplastic portal vein thrombosis in patients with hepatic cirrhosis?纤维蛋白溶解功能降低在肝硬化患者非肿瘤性门静脉血栓形成过程中起作用吗？
Intern Emerg Med. 2014 Jun;9(4):397-403. doi: 10.1007/s11739-013-0929-7. Epub 2013 Mar 17.

本文引用的文献

1
Laboratory evaluation of a new integrative assay to phenotype plasma fibrinolytic system.一种用于血浆纤维蛋白溶解系统表型分析的新型综合检测方法的实验室评估。
Thromb J. 2022 Dec 5;20(1):73. doi: 10.1186/s12959-022-00435-6.
2
Fibrinolysis in Patients with Liver Disease.肝病患者的纤维蛋白溶解。
Semin Thromb Hemost. 2021 Jul;47(5):601-609. doi: 10.1055/s-0040-1718924. Epub 2021 Mar 26.
3
Evidence for a rebalanced hemostatic system in pediatric liver transplantation: A prospective cohort study.在儿科肝移植中止血系统再平衡的证据：一项前瞻性队列研究。
Am J Transplant. 2020 May;20(5):1384-1392. doi: 10.1111/ajt.15748. Epub 2020 Jan 8.
4
Lysis Timer: a new sensitive tool to diagnose hyperfibrinolysis in liver transplantation.溶酶体计时：一种诊断肝移植中纤维蛋白溶解亢进的新敏感工具。
J Clin Pathol. 2019 Jan;72(1):58-65. doi: 10.1136/jclinpath-2018-205280. Epub 2018 Oct 3.
5
Coagulation Failure in Patients With Acute-on-Chronic Liver Failure and Decompensated Cirrhosis: Beyond the International Normalized Ratio.慢加急性肝衰竭和失代偿期肝硬化患者的凝血功能衰竭：不止国际标准化比值。
Hepatology. 2018 Dec;68(6):2325-2337. doi: 10.1002/hep.30103. Epub 2018 Nov 9.
6
A new assay for global fibrinolysis capacity (GFC): Investigating a critical system regulating hemostasis and thrombosis and other extravascular functions.一种用于评估整体纤维蛋白溶解能力（GFC）的新检测方法：探究调节止血、血栓形成及其他血管外功能的关键系统。
Transfus Apher Sci. 2018 Feb;57(1):118-126. doi: 10.1016/j.transci.2018.02.020. Epub 2018 Feb 20.
7
Decreased Plasma Fibrinolytic Potential As a Risk for Venous and Arterial Thrombosis.血浆纤维蛋白溶解潜能降低作为静脉和动脉血栓形成的一个风险因素。
Semin Thromb Hemost. 2017 Mar;43(2):178-184. doi: 10.1055/s-0036-1585081. Epub 2016 Jul 29.
8
The coagulopathy of chronic liver disease.慢性肝病的凝血功能障碍
N Engl J Med. 2011 Jul 14;365(2):147-56. doi: 10.1056/NEJMra1011170.
9
Thrombin generation, fibrin clot formation and hemostasis.凝血酶生成、纤维蛋白凝块形成与止血。
Transfus Apher Sci. 2008 Feb;38(1):15-23. doi: 10.1016/j.transci.2007.12.005. Epub 2008 Feb 20.
10
Reduced plasma fibrinolytic potential is a risk factor for venous thrombosis.血浆纤溶潜力降低是静脉血栓形成的一个危险因素。
Blood. 2005 Feb 1;105(3):1102-5. doi: 10.1182/blood-2004-08-3253. Epub 2004 Oct 5.